Literature DB >> 2689019

The mechanism of action of terbinafine.

N S Ryder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2689019     DOI： 10.1111/j.1365-2230.1989.tb00900.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  9 in total

Review 1.  [Anti-fungal drugs. Current status and guidelines for their administration].

Authors:  Rodrigo Fernández Alonso; Maria Esther González García; Joaquín Fernández García; Francisco Javier Cepeda Piorno
Journal:  Clin Transl Oncol       Date:  2005-10       Impact factor: 3.405

2.  Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds.

Authors:  Marija Tubic-Grozdanis; Michael B Bolger; Peter Langguth
Journal:  AAPS J       Date:  2008-04-02       Impact factor: 4.009

3.  Antifungal agents for common paediatric infections.

Authors: 
Journal:  Paediatr Child Health       Date:  2000-11       Impact factor: 2.253

Review 4.  Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections.

Authors:  R Davis; J A Balfour
Journal:  Pharmacoeconomics       Date:  1995-09       Impact factor: 4.981

Review 5.  Current management of fungal infections.

Authors:  J F Meis; P E Verweij
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 6.  Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses.

Authors:  J A Balfour; D Faulds
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

7.  [Modern antimycotics. What the treating physician needs to know].

Authors:  C Seebacher
Journal:  Hautarzt       Date:  2004-02       Impact factor: 0.751

Review 8.  Strategies to Better Target Fungal Squalene Monooxygenase.

Authors:  Alia A Sagatova
Journal:  J Fungi (Basel)       Date:  2021-01-13

9.  Candida albicans Infections: a novel porcine wound model to evaluate treatment efficacy.

Authors:  Joel Gil; Michael Solis; Alexander Higa; Stephen C Davis
Journal:  BMC Microbiol       Date:  2022-02-04       Impact factor: 3.605
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.